Viridian Therapeutics, Inc. (VRDN)
29.29
-0.96
(-3.17%)
USD |
NASDAQ |
Mar 03, 09:30
Viridian Therapeutics EPS Diluted (Quarterly) : -1.080 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1193 |
| ADMA Biologics, Inc. | 0.2025 |
| Avantor, Inc. | 0.0771 |
| Immunovant, Inc. | -0.6095 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -101.98M |
| Revenue (Quarterly) | 0.132M |
| Total Expenses (Quarterly) | 102.11M |
| Enterprise Value | 2.195B |
| Gross Profit Margin (Quarterly) | -142.4% |
| Profit Margin (Quarterly) | -77.26K% |
| Earnings Yield | -13.00% |
| Normalized Earnings Yield | -12.98 |